Saturday, 7 November 2026 कौन ज़िम्मेदार?
कौन ज़िम्मेदार?KaunZimmedar

Every story is a real government document.

Markets Reserve Bank of India

RBI awards ₹17 crore drug supply contract to five suppliers simultaneously

The Reserve Bank of India (Mumbai Regional Office) is contracting for the supply of drugs, medicines, and non-medical items to its dispensaries in the Mumbai and Navi Mumbai region.

₹17 crContract Value: ₹17.00 Crore

Key terms

  • Tender Type: E-tender, Two bid system
  • Contract Value: ₹17.00 Crore
  • Bid Submission Deadline: Apr 28, 2026 at 11.00 AM
  • Contract Start Date: May 04, 2026
  • Scheduled Completion Date: Mar 31, 2027
  • Award Basis: Highest discount (H1)

Also in the document

  • The contract was awarded to five different suppliers simultaneously rather than a single entity.
  • The award was based on the 'Highest discount (H1)' rather than the lowest evaluated price.

Who won this contract: 1. M/s Tata 1Mg Healthcare Solutions Private Limited, ₹17.00 — read from the award document; check the original.

How this was written

An AI model running on our own computer read the government document and wrote this summary. No person has checked it.

✓ Figures checked. Every number in this summary was found in the document by an automated check.

That check compares numbers only. It cannot confirm that the wording says what the document says — so the original document is always the authority.

How we work · Report an error in this story

The original document

Reserve Bank of India (RBI)

Tender · Ref. RBI/MumbaiRegionalOffice/HRMD/1/26-27/ET/10 · 30 Jun 2026

Award 30 Jun 2026 On rbi.org.in ↗

Discussion

Discuss the documents, not people. No doxxing of private individuals. Do not state allegations of crime or wrongdoing as fact — ask questions instead. Be civil. Posts that break these rules may be removed by moderators.

Sign in with Google to post

No one has discussed this document yet.